HAYWARD, Calif., June 20, 2013 /PRNewswire/ -- Solta Medical,
Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin
treatments, today announced it has received a new FDA 510(k)
clearance of its Fraxel® DUAL 1550/1927 laser system for the
treatment of pigmented lesions such as, but not limited to lentigos
(age spots), solar lentigos (sun spots) and ephelides
(freckles).
"The Fraxel DUAL 1550/1927 provides patients superior anti-aging
results, specifically when treating pigmentation of the skin caused
by sun exposure," said Roy G.
Geronemus, MD, director of the Laser & Skin Surgery
Center of New York and clinical
professor of dermatology at New York
University Medical Center. "The additional FDA clearance for
Fraxel DUAL is a breakthrough in the treatment, improvement, and
correction of undesired skin pigmentation. With the 1927 nm
wavelength, patients can see significant results with very little
downtime."
In addition to the treatment of pigmented lesions, the Fraxel
DUAL system is indicated for use in dermatological procedures
requiring the coagulation of soft tissue, as well as for skin
resurfacing procedures. Specific additional indications include
actinic keratosis (AKs), melasma, treatment of periorbital
wrinkles, acne scars and surgical scars.
The Fraxel DUAL system is an unsurpassed breakthrough skin
resurfacing technology that renews skin and helps maintain skin's
youthful glow despite a person's age or skin color, with minimal
discomfort and downtime. It is a fractional laser system that
safely penetrates the skin down to the dermis without disrupting
the skin's protective outer barrier, thus maximizing safety and
recovery time. The result is natural stimulation of new collagen
creation, which exists naturally in the dermis to provide
structural support and gradually breaks down throughout the aging
process weakening the skin, leading to fine lines, wrinkles and
sagging skin.
"Solta Medical is committed to developing safe, effective
treatments to advance the aesthetic industry," said Stephen J. Fanning, President and CEO of Solta
Medical, Inc. "With the additional FDA clearance of our Fraxel DUAL
system, we are enhancing the cutting-edge technology offered by our
physicians and sought by patients, specifically in treating
pigmentation and actinic keratosis caused by sun damage."
For more information about the Fraxel® DUAL Laser System, please
visit http://fraxel.com.
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers aesthetic energy devices for
skin resurfacing and rejuvenation, acne reduction, body contouring
and skin tightening, as well as tools and accessories to optimize
the latest liposuction techniques. Each brand is an established
category leader, and together comprise of a comprehensive platform
to address a range of aesthetic skin and body issues.
Fraxel® delivers minimally-invasive clinical solutions
to resurface aging and sun damaged skin. Clear +
Brilliant® is a cost-effective, non-ablative laser
treatment uniquely designed to improve skin tone and radiance.
Isolaz® acne treatment combines vacuum and painless
broadband light to address a wide variety of acne types.
CLARO® is an FDA-cleared personal care acne device that
uses heat and light to clear skin quickly and naturally.
Thermage® is a non-invasive radiofrequency procedure
that improves the appearance of wrinkles, which can result in
smoother, more contoured skin. Liposonix® is a
non-surgical single-treatment procedure that uses advanced
high-intensity focused ultrasound technology to destroy targeted
fat beneath the skin. VASERshape™ is a complementary
non-invasive treatment that combines low frequency, non-focused
ultrasound and lymphatic massage to temporarily reduce the
appearance of cellulite and improve blood circulation with minimal
pain or no downtime. The VASERlipo™ system uses
ultrasound technology to selectively remove unwanted body fat. It
includes VentX® technology that powers an aspiration
system for quiet, efficient removal of fatty tissue and precision
vented cannulas to maximize aspiration efficiency and speed.
VASERsmooth™ is a unique body sculpting add-on tool for
use with the VASERlipo system. PowerX® is a
power-assisted liposuction system that uses a unique rotational
motion which can be used with the VASERlipo system or to enhance
traditional liposuction systems. The TouchView® system
fits between the fingers and provides diagnostic imaging of
subcutaneous structures during procedures. Both the VASERlipo
system and traditional liposuction systems can utilize the
Origins™ products, a complete line of custom liposuction
infiltration, re-injection and aspiration cannulas and accessories.
More than two and a half million procedures have been performed
with Solta Medical's portfolio of products around the world.
SOURCE Solta Medical, Inc.